PMID- 33191698 OWN - NLM STAT- MEDLINE DCOM- 20201117 LR - 20220418 IS - 1002-1892 (Print) IS - 1002-1892 (Linking) VI - 34 IP - 11 DP - 2020 Nov 15 TI - [Effect of glycoside of short-horned epimedium Herb on the expressions of transforming growth factor beta (1) and basic fibroblast growth factor induced membrane by Masquelet technology]. PG - 1405-1409 LID - 10.7507/1002-1892.201905060 [doi] AB - OBJECTIVE: To observe the expressions of transforming growth factor beta (1) (TGF-beta (1)) and basic fibroblast growth factor (bFGF) induced membrane by Masquelet technique in rats treated with glycoside of short-horned epimedium Herb, and to explore the effect of glycoside of short-horned epimedium Herb on Masquelet induced membrane. METHODS: Sixty 3-month-old male Wistar rats were randomly divided into 3 groups with 20 rats in each group; a tibial bone defect (6 mm in length) model was established. The blank group (group A) was not treated; the control group (group B) and the experimental group (group C) were filled with vancomycin antibiotic bone cement in the drawing stage, and the bone cement was completely solidified. Group C was given perfused flavonoids glycoside of short-horned epimedium Herb (10 mumol/L) by gavage once a day (0.3 mL) from 1 day after operation, and groups A and B were given the same amount of normal saline by gavage. After operation, the recovery and wound healing of experimental animals were observed; at 4 weeks after operation, X-ray film was taken to observe the recovery of bone defect of proximal tibia; at 6 weeks after operation, the bone defect was observed, and the morphological changes and vascularization degree of granulation tissue and induction membrane tissue were observed; the expressions of TGF-beta (1) and bFGF were observed by immunohistochemistry staining and ELISA detection. RESULTS: The bone defect models of the 3 groups were established successfully, and there was no abnormality after operation. The incisions healed by first intention after operation. At 4 weeks after operation, X-ray films of proximal tibial defect showed that there was obvious space in group A, while bone cement was filled and Kirschner wire fixation was good in groups B and C. At 6 weeks after operation, the gross observation showed that the granulation tissue was filled in the defect area in group A; transparent membrane was formed in groups B and C, and microvessels were seen in some areas, and the microvessels in group C were significantly more than those in group B. Immunohistochemical staining showed that the expressions of TGF-beta (1) and bFGF were negative in group A, but they were expressed in groups B and C, and the expressions of TGF-beta (1) and bFGF in group B were significantly less than those in group C. ELISA detection showed that the expressions of TGF-beta (1) and bFGF in group C were significantly higher than those in groups A and B ( P<0.05), but there was no significant difference between groups A and B ( P>0.05). CONCLUSION: Glycoside of short-horned epimedium Herb can significantly increase the expressions of TGF-beta (1) and bFGF, accelerate the process of osteogenesis, and contribute to bone shaping and reconstruction. FAU - Ding, Qiang AU - Ding Q AD - Department of Osteonecrosis, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), Luoyang Henan, 471002, P.R.China. FAU - Sun, Nan AU - Sun N AD - Department of Osteonecrosis, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), Luoyang Henan, 471002, P.R.China. FAU - Wang, Xiaohui AU - Wang X AD - Department of Osteonecrosis, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), Luoyang Henan, 471002, P.R.China. LA - chi PT - Journal Article PL - China TA - Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi JT - Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery JID - 9425194 RN - 0 (Glycosides) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 103107-01-3 (Fibroblast Growth Factor 2) SB - IM MH - Animals MH - *Epimedium MH - *Fibroblast Growth Factor 2 MH - Glycosides/pharmacology MH - Male MH - Rats MH - Rats, Wistar MH - Transforming Growth Factor beta MH - Transforming Growth Factor beta1 MH - Wound Healing PMC - PMC8171696 OTO - NOTNLM OT - Bone defect OT - Masquelet technique OT - basic fibroblast growth factor OT - glycoside of short-horned epimedium Herb OT - osteogenic activity OT - transforming growth factor beta1 COIS- 利益冲突:所有作者声明,在课题研究和文章撰写过程中不存在利益冲突。课题经费支持没有影响文章观点和对研究数据客观结果的统计分析及其报道。 EDAT- 2020/11/17 06:00 MHDA- 2020/11/18 06:00 PMCR- 2020/11/01 CRDT- 2020/11/16 06:01 PHST- 2020/11/16 06:01 [entrez] PHST- 2020/11/17 06:00 [pubmed] PHST- 2020/11/18 06:00 [medline] PHST- 2020/11/01 00:00 [pmc-release] AID - zgxfcjwkzz-34-11-1405 [pii] AID - 10.7507/1002-1892.201905060 [doi] PST - ppublish SO - Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Nov 15;34(11):1405-1409. doi: 10.7507/1002-1892.201905060.